Bundle Branch Pacing to Preserve Ejection Fraction in Atrial Fibrillation Trial

Study acronym: BEAT
StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 months later Aug 14, 2028 → Oct 14, 2028
See other at-risk trials from Poitiers University Hospital

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Recruitment opened Show 6 more changesShow less
    • Primary completion pushed from Aug 14, 2028 to Oct 14, 2028
    • Study sites: 0 to 1
    • Start date changed from estimate of Sep 15, 2026 to Oct 15, 2026
    • Eligibility criteria expanded, about 15 words
    • Secondary endpoints: details revised at 3 of 10 entries
    • Collaborators revised (9)
  2. Minor Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
The goal of this clinical trial is to learn whether left bundle branch area pacing, a technique designed to activate the heart's natural electrical conduction system, is better than conventional right ventricular pacing in adults with permanent atrial fibrillation, preserved heart pumping function, and a need for a pacemaker. The main questions it aims to answer are: Does left bundle branch area pacing reduce the risk of death, unplanned hospitalization for heart failure, or the need to replace the initial pacing system with biventricular pacing over 2 years? Does it better preserve heart function and quality of life, without increasing pacemaker-related complications? Researchers will compare left bundle branch area pacing with conventional right ventricular pacing. A total of 642 participants will be randomly assigned to receive one of these two pacing strategies. Participants will: Have a single-chamber pacemaker implanted using either left bundle branch area pacing or conventional right ventricular pacing Undergo electrocardiograms, echocardiograms, and pacemaker checks during 2 years of follow-up Attend follow-up visits approximately 2, 12, and 24 months after implantation Be contacted by telephone approximately 6 and 18 months after implantation Complete questionnaires about their health and quality of life at the beginning and end of the study
Trial Details
NCT Number NCT07759700
Lead Sponsor Poitiers University Hospital
Collaborators: University Hospital, Grenoble, Nouvelles Cliniques Nantaises, Nantes, Centre Hospitalier Universitaire de Besancon, Centre Hospitalier de PAU, Centre Cardiologique du Nord, St Denis, Centre Hospitalier Universitaire de Saint Etienne, Centre Hospitalier Departemental Vendee, Centre Hospitalier Régional d'Orléans, University Hospital, Tours
Conditions
(from sponsor)
Permanent Atrial Fibrillation, Preserved Ejection Fraction
Related terms Atrial Fibrillation, Heart Failure
Enrollment 642 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov